Evidence map›Paper›PMID 39525157›Full record

ArticleCureus2024

Pancytopenia, Cholestatic Jaundice, and Pulmonary Hypertension: Rare Extrathyroidal Manifestations of Graves' Disease.

John Khor, Teoh Jamie Hong Im

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

John KhorInternal Medicine, Hospital Sultanah Nora Ismail, Batu Pahat, MYS.
Teoh Jamie Hong ImEndocrinology, Hospital Sultanah Aminah, Johor Bahru, MYS.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancytopenia, cholestatic jaundice, and pulmonary hypertension are rare but serious complications of thyrotoxicosis. It is uncommonly seen in patients with hyperthyroidism and may result in treatment-related dilemmas as bone marrow suppression and drug-induced liver injury are known complications of anti-thyroid treatment.  We describe a case of Graves' disease presenting with all three manifestations of pancytopenia, cholestatic jaundice, and pulmonary hypertension during a relapse of thyrotoxicosis. Her anti-thyroid medications were initially withheld for fear of worsening the above manifestations, but no improvement was noted clinically or biochemically. Other lab investigations, such as hepatitis serology, autoimmune liver markers, and ultrasound, were unrevealing. Anti-thyroid medications were subsequently reinitiated after discussion with the endocrine team, with improvements in clinical condition, as well as full blood counts and liver function tests. Pulmonary hypertension also improved on her latest echocardiography.  This case report intends to shed light on the atypical extrathyroidal manifestations of Grave's disease and the importance of recognition and therapy.

Indexed as

antithyroid drugcardiomyopathycholestatic jaundicegraves’ diseasepancytopenia

Identifiers

PMID39525157
PMCPMC11549387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.